Freestone Capital Holdings LLC Sells 32,395 Shares of Colgate-Palmolive Company $CL

Key Points

• Freestone Capital Holdings cut its stake in Colgate‑Palmolive by 80.9%, selling 32,395 shares and leaving it with 7,628 shares valued at about $603,000 at quarter end.
• Company insiders have been net sellers recently — including COO Panagiotis Tsourapas who sold 35,000 shares — with insiders selling 184,683 shares worth roughly $17.49M over the last 90 days (insiders now own 0.43%).
• Analysts hold a consensus of "Moderate Buy" with a price target of $95.56; Colgate raised its quarterly dividend to $0.53 (a 2.5% yield) and reported a quarterly EPS beat of $0.95 with revenue up 5.8% year‑over‑year.

Freestone Capital Holdings LLC lessened its stake in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 80.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 7,628 shares of the company's stock after selling 32,395 shares during the quarter. Freestone Capital Holdings LLC's holdings in Colgate-Palmolive were worth $603,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of CL. Maseco LLP bought a new stake in Colgate-Palmolive during the 4th quarter valued at $27,000. Copia Wealth Management bought a new stake in Colgate-Palmolive during the 3rd quarter valued at $29,000. Cloud Capital Management LLC bought a new stake in Colgate-Palmolive during the 3rd quarter valued at $30,000. Global Wealth Strategies & Associates boosted its position in Colgate-Palmolive by 300.0% during the 4th quarter. Global Wealth Strategies & Associates now owns 400 shares of the company's stock valued at $32,000 after acquiring an additional 300 shares in the last quarter. Finally, Grove Bank & Trust boosted its position in Colgate-Palmolive by 182.6% during the 4th quarter. Grove Bank & Trust now owns 407 shares of the company's stock valued at $32,000 after acquiring an additional 263 shares in the last quarter. Institutional investors own 80.41% of the company's stock.

Analyst Ratings Changes

Several analysts have issued reports on CL shares. Wells Fargo & Company dropped their target price on Colgate-Palmolive from $100.00 to $92.00 and set an "equal weight" rating on the stock in a research report on Wednesday, April 8th. Weiss Ratings reiterated a "hold (c)" rating on shares of Colgate-Palmolive in a report on Wednesday, January 21st. Royal Bank Of Canada set a $102.00 price objective on Colgate-Palmolive in a report on Thursday, April 9th. Citigroup increased their price objective on Colgate-Palmolive from $95.00 to $105.00 and gave the company a "buy" rating in a report on Monday, February 2nd. Finally, TD Cowen reiterated a "hold" rating and set a $85.00 price objective on shares of Colgate-Palmolive in a report on Tuesday, March 31st. Eleven equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $95.56.

Colgate-Palmolive Stock Performance

Shares of CL opened at $83.49 on Thursday. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $99.33. The stock has a fifty day moving average price of $90.39 and a 200-day moving average price of $83.67. The company has a current ratio of 0.83, a quick ratio of 0.54 and a debt-to-equity ratio of 18.82. The firm has a market cap of $66.98 billion, a PE ratio of 31.87, a P/E/G ratio of 4.19 and a beta of 0.34.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings data on Friday, January 30th. The company reported $0.95 EPS for the quarter, beating the consensus estimate of $0.91 by $0.04. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The firm had revenue of $5.23 billion during the quarter, compared to analyst estimates of $5.13 billion. During the same quarter in the prior year, the business posted $0.91 EPS. The business's revenue for the quarter was up 5.8% compared to the same quarter last year. Equities research analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Monday, April 20th will be paid a $0.53 dividend. This is a positive change from Colgate-Palmolive's previous quarterly dividend of $0.52. The ex-dividend date is Monday, April 20th. This represents a $2.12 dividend on an annualized basis and a yield of 2.5%. Colgate-Palmolive's dividend payout ratio (DPR) is 80.92%.

Insider Transactions at Colgate-Palmolive

In related news, COO Panagiotis Tsourapas sold 35,000 shares of the firm's stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $94.61, for a total value of $3,311,350.00. Following the completion of the transaction, the chief operating officer owned 10,415 shares in the company, valued at $985,363.15. This trade represents a 77.07% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Sally Massey sold 15,851 shares of the firm's stock in a transaction on Thursday, February 5th. The stock was sold at an average price of $95.03, for a total value of $1,506,320.53. Following the completion of the transaction, the insider owned 13,751 shares of the company's stock, valued at $1,306,757.53. This trade represents a 53.55% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 184,683 shares of company stock worth $17,486,693. Insiders own 0.43% of the company's stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company's core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.